Bezitramide

Bezitramide is a narcotic analgesic utilized for pain management. Unlike direct-acting opioids, Bezitramide functions primarily as a prodrug, undergoing hydrolysis in the gastrointestinal tract to produce its active metabolite, despropionyl-bezitramide. Originally discovered in 1961 by the pharmaceutical company Janssen Pharmaceutica, it was later sold predominantly under the brand name Burgodin.

Bezitramide

Pharmacology

Mechanism of Action

As a prodrug, Bezitramide itself is not responsible for its analgesic effects. Instead, once ingested, it is swiftly converted in the gastrointestinal system to despropionyl-bezitramide, the compound that provides pain-relieving effects.

History

Discovery and Marketing

The origins of Bezitramide can be traced back to 1961, when it was synthesized and developed by the researchers at Janssen Pharmaceutica. Marketed prominently as Burgodin, it provided an alternative in the realm of pain management drugs.

Controversies and Withdrawal

Despite its medical applications, Bezitramide's safety profile became a significant concern. A series of fatal overdoses associated with the drug led to mounting scrutiny. Notably, a tragic incident wherein a five-year-old child consumed a single tablet, leading to fatal consequences, drew considerable attention to the drug's potency and potential risks. Consequently, in 2004, the drug was officially withdrawn from the market in the Netherlands.

Legal Status

In light of its potency and associated risks, Bezitramide is stringently regulated across various jurisdictions. In the United States, it falls under Schedule II of the Controlled Substances Act of 1970, bearing the ACSCN (Administrative Controlled Substance Code Number) of 9800. This classification places it alongside other substances with a high potential for abuse, such as morphine. It's noteworthy that, despite this categorization, Bezitramide has never been officially marketed or widely available in the U.S.

Current Use

While Bezitramide was removed from certain markets due to concerns about its safety profile, its legacy serves as a reminder of the complexities associated with drug development, regulation, and safety assurance.

See also

• Narcotic analgesic
• Prodrug
• Controlled Substances Act
• Janssen Pharmaceutica

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

This analgesic-related article is a stub. You can help WikiMD by expanding it.